Healthcare revenue cycle automation platform using AI to streamline medical coding, claims, and prior authorization processes.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
AKASA offers innovative solutions for the healthcare revenue cycle, using generative AI technology to streamline operations and reduce inefficiencies. The company assists health organizations in achieving improved staff performance, reduced operating expenses, and faster processing—all while improving the patient experience—by concentrating on areas such as medical coding, claim administration, and prior authorization.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
AKASA Management Team
AKASA Valuations & Financials
View real-time NPM data on AKASA stock including daily AKASA stock price estimates, valuation history, and historical share price information. Access AKASA financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track AKASA pricing across six independent market signals. Looking for private company due diligence data sources on AKASA? Get in touch to learn more.
Similar Companies
like AKASA
Truveta
Healthcare & Life Sciences
A healthcare data analytics platform that aggregates anonymized health data from various providers.
Altos Labs
Healthcare & Life Sciences
Pioneers cellular reprogramming to extend lifespan by reversing aging effects through advanced regenerative technologies.
Kartos Therapeutics
Healthcare & Life Sciences
Develops targeted cancer therapies, with a focus on reactivating tumor-suppressing pathways.
Mindbloom
Healthcare & Life Sciences
Provides supervised at-home ketamine therapy services to treat mental health conditions through personalized treatment programs.
Boulder
Healthcare & Life Sciences
Digital platform delivers medication-assisted addiction treatment and specialist support through telehealth services.
Carta Healthcare
Healthcare & Life Sciences
Streamlines and enhances the process of abstracting and managing clinical data for hospitals and health systems.
LENZ Therapeutics
Healthcare & Life Sciences
A biopharmaceutical company that develops ophthalmic products to improve vision, focusing on treatments for presbyopia.
Healthie
Healthcare & Life Sciences
Digital healthcare platform providing practice management and EHR solutions with integrated scheduling, billing, and telehealth services.
FAQ
We have answers
AKASA stock does not trade on public stock exchanges. AKASA stock is considered a private security and you need to be an accredited investor to trade shares. To invest in AKASA stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
AKASA Stock does not trade on public stock exchanges. In order to sell AKASA shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
AKASA does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view AKASA share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for AKASA stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell AKASA stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in AKASA stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
AKASA is a private company and has not had an IPO. There is currently no AKASA IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to AKASA IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
